Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

QUALIGEN Aktie

>QUALIGEN Performance
1 Woche: 0%
1 Monat: 0%
3 Monate: 0%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>QUALIGEN Aktie
Name:  QUALIGEN THERAPEUTICS
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US74754R3012 / A40THA
Symbol/ Ticker:  7R90 (Frankfurt) / QLGN (NASDAQ)
Kürzel:  FRA:7R90, ETR:7R90, 7R90:GR, NASDAQ:QLGN
Index:  -
Webseite:  https://qlgntx.com/
Marktkapitalisierung:  -
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / - / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  QUALIGEN
Letzte Datenerhebung:  24.06.25
>QUALIGEN Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
>QUALIGEN Peer Group

 
19.05.25 - 23:27
Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q (GlobeNewswire EN)
 
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on May 19, 2025 (the "Notice"). The Notice indicated that the Nasdaq Hearings Panel (the “Panel”) will consider the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 as an additional basis for delisting the Company's securities from The Nasdaq Stock Market....
01.05.25 - 22:24
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K (GlobeNewswire EN)
 
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on April 24, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c) (the “Listing Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the annual period ended December 31, 2024 (the “2024 Form 10-K”), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the "SEC") on April 1, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC....
09.04.25 - 15:06
Pre-market Movers: Venus Concept, Scworx, Greenfire Resources, Alta Equipment Group, Qualigen Therapeutics (AFX)
 
OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.25 A.M. ET).In the Green Venus Concept Inc (VERO) is up over 310% at $11.82. Sc......
05.11.24 - 08:32
XFRA : 7R90: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL QUALIGEN THER. DL-,001 7R90 US74754R3012 BAW/UFN...
05.11.24 - 07:57
XFRA : INSTRUMENT_SUSPENSION - US74754R3012 (XETRA)
 
Instrument ID [21504679] (7R90 - US74754R3012) suspended...
04.11.24 - 23:58
XFRA : NEW INSTRUMENT AVAILABLE - 05.11.2024 - US74754R3012 (XETRA)
 
Das Instrument 7R90 US74754R3012 QUALIGEN THER. DL-,001 EQUITY hat seinen ersten Handelstag am 05.11.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument 7R90 US74754R3012 QUALIGEN THER. DL-,001 EQUITY has its first trading date on 05.11.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
04.11.24 - 16:44
XFRA : ISIN Change (XETRA)
 
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen US03837J1016 Aqua Metals Inc. 04.11.2024 US03837J2006 Aqua Metals Inc. 05.11.2024 Tausch 20:1 US74754R2022 Qualigen Therapeutics Inc. 04.11.2024 US74754R3012 Qualigen Therapeutics Inc. 05.11.2024 Tausch 50:1 VGG982181031 VCI Global Ltd. 04.11.2024 VGG982182021 VCI Global Ltd. 05.11.2024 Tausch 49:1...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!